Comparative in vitro stimulation with lipopolysaccharide to study TNFalpha gene expression in fresh whole blood, fresh and frozen peripheral blood mononuclear cells

J Immunol Methods. 2010 May 31;357(1-2):33-7. doi: 10.1016/j.jim.2010.03.006. Epub 2010 Mar 20.

Abstract

In vitro stimulation with fresh and frozen peripheral blood mononuclear cells (PBMCs) or fresh whole blood has been widely used in animal studies and clinical trials to study the immunological features of a number of human diseases. The objective of this study was to determine the difference in response to stimulation of fresh PBMCs, frozen PBMCs, and fresh whole blood by change of TNFalpha gene expression levels after 4-hour in vitro lipopolysaccharide (LPS) stimulation. Our results demonstrate that TNFalpha gene expression significantly increases in both fresh PBMCs and fresh whole blood when 1 microg/ml or 10 microg/ml LPS was used but only after stimulation with 10 microg/ml LPS in frozen PBMCs. Mean fold change of TNFalpha gene expression levels after 1 microg/ml LPS stimulation was significantly higher using fresh whole blood (51.01+/-7.91) as compared to fresh PBMCs (8.92+/-2.16) or frozen PBMCs (3.04+/-0.55) (p<or=0.007). The same trend was also observed with 10 microg/ml LPS stimulation (p<or=0.001). Decreased PBMC cell viability due to cryopreservation, cytokine depletion and removal of some minor cells during cell isolation could attribute to the low TNFalpha expression in the frozen PBMCs. Our results strongly suggest that fresh whole blood is the best choice for in vitro stimulation studies.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Survival
  • Cryopreservation*
  • Female
  • Gene Expression Regulation / drug effects*
  • Gene Expression Regulation / immunology
  • Humans
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / metabolism*
  • Lipopolysaccharides / pharmacology*
  • Male
  • Middle Aged
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha